UniProt ID | DDX51_HUMAN | |
---|---|---|
UniProt AC | Q8N8A6 | |
Protein Name | ATP-dependent RNA helicase DDX51 | |
Gene Name | DDX51 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 666 | |
Subcellular Localization | Nucleus, nucleolus. | |
Protein Description | ATP-binding RNA helicase involved in the biogenesis of 60S ribosomal subunits.. | |
Protein Sequence | MALFYVARYPGPDAAAAAGPEGAEAGAHGRARALLERLQSRARERQQQREPAQTEAAASTEPATRRRRRPRRRRRVNDAEPGSPEAPQGKRRKADGEDAGAESNEEAPGEPSAGSSEEAPGEPSAGSSEEAPGERSTSASAEAAPDGPALEEAAGPLVPGLVLGGFGKRKAPKVQPFLPRWLAEPNCVRRNVTEDLVPIEDIPDVHPDLQKQLRAHGISSYFPVQAAVIPALLESAACGFLVGRGGYRPSDLCVSAPTGSGKTLAFVIPVVQALLSRVVCHIRALVVLPTKELAQQVSKVFNIYTDATPLRVSLVTGQKSLAKEQESLVQKTADGYRCLADIVVATPGRLVDHIDQTPGFSLQQLRFLIIDEADRMIDSMHQSWLPRVVAAAFQSEDPADPCALLQRRQAQAVTAASTCCPQMPLQKLLFSATLTQNPEKLQQLGLHQPRLFSTGLAHRGLEDTDGDGDSGKYAFPVGLTHHYVPCSLSSKPLVVLHLVLEMGFSRVLCFTNSRENSHRLFLLVQAFGGVDVAEFSSRYGPGQRRMILKQFEQGKIQLLISTDATARGIDVQGVELVVNYDAPQYLRTYVHRVGRTARAGKTGQAFTLLLKVQERRFLRMLTEAGAPELQRHELSSKLLQPLVPRYEEALSQLEESVKEERKQRAA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MALFYVARY ------CCEEEEECC | 13.33 | 22223895 | |
8 | Methylation | MALFYVARYPGPDAA CCEEEEECCCCCHHH | 28.30 | - | |
30 | Methylation | AEAGAHGRARALLER HHCCHHHHHHHHHHH | 15.84 | - | |
59 | Phosphorylation | AQTEAAASTEPATRR HHHHHHHCCCHHHHH | 28.69 | 20860994 | |
60 | Phosphorylation | QTEAAASTEPATRRR HHHHHHCCCHHHHHH | 41.06 | 20860994 | |
64 | Phosphorylation | AASTEPATRRRRRPR HHCCCHHHHHHCCCC | 35.11 | 28555341 | |
83 | Phosphorylation | VNDAEPGSPEAPQGK CCCCCCCCCCCCCCC | 30.22 | 19664994 | |
90 | Acetylation | SPEAPQGKRRKADGE CCCCCCCCCCCCCCC | 43.72 | 25953088 | |
103 | Phosphorylation | GEDAGAESNEEAPGE CCCCCCCCCCCCCCC | 49.35 | 28355574 | |
112 | Phosphorylation | EEAPGEPSAGSSEEA CCCCCCCCCCCCCCC | 40.74 | 28176443 | |
115 | Phosphorylation | PGEPSAGSSEEAPGE CCCCCCCCCCCCCCC | 34.00 | 30278072 | |
116 | Phosphorylation | GEPSAGSSEEAPGEP CCCCCCCCCCCCCCC | 38.24 | 30278072 | |
124 | Phosphorylation | EEAPGEPSAGSSEEA CCCCCCCCCCCCCCC | 40.74 | 23663014 | |
127 | Phosphorylation | PGEPSAGSSEEAPGE CCCCCCCCCCCCCCC | 34.00 | 23663014 | |
128 | Phosphorylation | GEPSAGSSEEAPGER CCCCCCCCCCCCCCC | 38.24 | 23663014 | |
138 | Phosphorylation | APGERSTSASAEAAP CCCCCCCCCCCCCCC | 22.82 | - | |
211 | Ubiquitination | DVHPDLQKQLRAHGI CCCHHHHHHHHHCCC | 59.61 | 22817900 | |
235 | Phosphorylation | VIPALLESAACGFLV HHHHHHHHHHCCCEE | 22.57 | 24719451 | |
247 | Phosphorylation | FLVGRGGYRPSDLCV CEECCCCCCHHHEEE | 23.36 | 20068231 | |
250 | Phosphorylation | GRGGYRPSDLCVSAP CCCCCCHHHEEEECC | 33.93 | 20068231 | |
255 | Phosphorylation | RPSDLCVSAPTGSGK CHHHEEEECCCCCCC | 27.77 | 20068231 | |
258 | Phosphorylation | DLCVSAPTGSGKTLA HEEEECCCCCCCHHH | 43.63 | 20068231 | |
260 | Phosphorylation | CVSAPTGSGKTLAFV EEECCCCCCCHHHHH | 39.33 | 20068231 | |
291 | Ubiquitination | ALVVLPTKELAQQVS EEEEECHHHHHHHHH | 49.11 | - | |
299 | Ubiquitination | ELAQQVSKVFNIYTD HHHHHHHHHHCCCCC | 52.57 | - | |
304 | Phosphorylation | VSKVFNIYTDATPLR HHHHHCCCCCCCCCE | 10.32 | 22817900 | |
319 | Ubiquitination | VSLVTGQKSLAKEQE EEEHHCCHHHHHHHH | 49.10 | 29967540 | |
323 | Ubiquitination | TGQKSLAKEQESLVQ HCCHHHHHHHHHHHH | 66.28 | 29967540 | |
331 | Ubiquitination | EQESLVQKTADGYRC HHHHHHHHHCCHHHH | 37.90 | - | |
331 | Acetylation | EQESLVQKTADGYRC HHHHHHHHHCCHHHH | 37.90 | 26051181 | |
346 | Phosphorylation | LADIVVATPGRLVDH HEEEEEECCCCCCCC | 18.05 | 28674419 | |
402 | Glutathionylation | SEDPADPCALLQRRQ CCCCCCHHHHHHHHH | 4.25 | 22555962 | |
431 | Phosphorylation | PLQKLLFSATLTQNP HHHHHHHHHHHCCCH | 21.95 | 20068231 | |
433 | Phosphorylation | QKLLFSATLTQNPEK HHHHHHHHHCCCHHH | 29.19 | 20068231 | |
435 | Phosphorylation | LLFSATLTQNPEKLQ HHHHHHHCCCHHHHH | 23.19 | 19664994 | |
440 | Ubiquitination | TLTQNPEKLQQLGLH HHCCCHHHHHHCCCC | 53.50 | 29967540 | |
464 | Phosphorylation | AHRGLEDTDGDGDSG CCCCCCCCCCCCCCC | 32.29 | 28674419 | |
470 | Phosphorylation | DTDGDGDSGKYAFPV CCCCCCCCCCEEEEE | 42.59 | 28985074 | |
490 | Phosphorylation | YVPCSLSSKPLVVLH EECCCCCCCCCHHHH | 43.52 | 24719451 | |
561 | Phosphorylation | GKIQLLISTDATARG CCEEEEEECCCCCCC | 21.87 | 20068231 | |
562 | Phosphorylation | KIQLLISTDATARGI CEEEEEECCCCCCCC | 23.74 | 20068231 | |
565 | Phosphorylation | LLISTDATARGIDVQ EEEECCCCCCCCCCC | 21.50 | 20068231 | |
585 | Phosphorylation | VNYDAPQYLRTYVHR EECCHHHHHHHHHHH | 9.33 | - | |
588 | Phosphorylation | DAPQYLRTYVHRVGR CHHHHHHHHHHHHCC | 27.57 | - | |
596 | Phosphorylation | YVHRVGRTARAGKTG HHHHHCCCCCCCCCC | 17.99 | 24719451 | |
601 | Acetylation | GRTARAGKTGQAFTL CCCCCCCCCCHHHHH | 48.80 | 25953088 | |
601 | Ubiquitination | GRTARAGKTGQAFTL CCCCCCCCCCHHHHH | 48.80 | - | |
607 | Phosphorylation | GKTGQAFTLLLKVQE CCCCHHHHHHHHHHH | 21.36 | 28674151 | |
620 | Sulfoxidation | QERRFLRMLTEAGAP HHHHHHHHHHHCCCH | 6.21 | 21406390 | |
635 | Phosphorylation | ELQRHELSSKLLQPL HHHHHHHHHHHHHHH | 23.57 | 27174698 | |
636 | Phosphorylation | LQRHELSSKLLQPLV HHHHHHHHHHHHHHH | 39.69 | 27174698 | |
637 | Ubiquitination | QRHELSSKLLQPLVP HHHHHHHHHHHHHHH | 50.25 | 22505724 | |
658 | Acetylation | SQLEESVKEERKQRA HHHHHHHHHHHHHHH | 64.24 | 26051181 | |
658 | Ubiquitination | SQLEESVKEERKQRA HHHHHHHHHHHHHHH | 64.24 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DDX51_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DDX51_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DDX51_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of DDX51_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83 AND SER-103, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83 AND SER-103, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY. |